(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide Struktur
1372719-93-1
CAS-Nr.
1372719-93-1
Englisch Name:
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide
Synonyma:
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;(11aR)-5-oxide-10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9- phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2] dioxaphosphocin;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-, 5-oxide, (11aR)-;(11AR)-10,11,12,13-TETRAHYDRO-5-HYDROXY-3,7-DI-9-PHENANTHRENYL-5-OXIDE-DIINDENO[7,1-DE:1',7'-FG][1,3,2]DIOXAPHOSPHOCIN,MIN.98%;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin,99%e.e.;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%
CBNumber:
CB02657811
Summenformel:
C45H31O4P
Molgewicht:
666.7
MOL-Datei:
1372719-93-1.mol

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide Eigenschaften

Dichte
1.46
Aggregatzustand
Powder
pka
1.14±0.20(Predicted)
Farbe
white to light-yellow
CAS Datenbank
1372719-93-1

Sicherheit

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide Chemische Eigenschaften,Einsatz,Produktion Methoden

Reaktionen

  1. Catalytic asymmetric homo-1,3-dipolar cycloadditions of azomethine ylides: diastereo and enantioselective synthesis of imidazolidines
  2. Enantioselective construction of the biologically significant dibenzo[1,4]diazepine scaffold via organocatalytic asymmetric three-component reactions
  3. Enantioselective construction of the biologically important cyclopenta[1,4]diazepine framework enabled by asymmetric catalysis by chiral spiro-phosphoric acid.
  4. Triply hydrogen-bond-directed enantioselective assembly of pyrrolobenzo-1,4-diazine skeletons with quaternary stereocenters.
Reactions of 1372719-93-1_1
Reactions of 1372719-93-1_2

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Daicel Chiral Technologies (China)CO.,LTD 021-50460086-9 15921403865
han_yajun@dctc.daicel.com China 6818 65
Tianjin Derchemist Science & Technology Co., Ltd. 22-58627059 13920586291
zdcomcon@126.com China 2918 50
Shanghai Chiral bio-compound co., Ltd. 021-5068 3667/17749785980/1029026415; 17749785980
1029026415@qq.com China 2790 58
Greenherbs Science and Technology Development Co., Ltd. 010-61136123
pub02@greenherbs.com.cn China 4049 58
Shanghai Jizhi Biochemical Technology Co. Ltd. 400-400-400-9004166 18616739031
3007523370@qq.com China 52712 58
Beijing Aomi Jiade Pharmaceutical Technology Co., Ltd 13522808617
omiget@qq.com China 9213 58
Energy Chemical 021-58432009 400-005-6266
marketing@energy-chemical.com China 44941 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-8210725 4008210725
malulu@leyan.com China 39997 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb5@aikonchem.com China 10529 58

  • (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide
  • (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9- phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2] dioxaphosphocin
  • (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin,99%e.e.
  • (11AR)-10,11,12,13-TETRAHYDRO-5-HYDROXY-3,7-DI-9-PHENANTHRENYL-5-OXIDE-DIINDENO[7,1-DE:1',7'-FG][1,3,2]DIOXAPHOSPHOCIN,MIN.98%
  • (11aR)-5-oxide-10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
  • (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%
  • Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-, 5-oxide, (11aR)-
  • (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
  • 1372719-93-1
  • C45H31O4P
Copyright 2019 © ChemicalBook. All rights reserved